McAllen makes $1 million contribution to UTRGV School of Medicine

Translate to Spanish or other 102 languages!

The City of McAllen presented a check for $1 million to The UTRGV School of Medicine on Wednesday, Oct. 11, 2017, at the Medical Education Building on the Edinburg Campus. From left are McAllen City Commissioner Omar Quintanilla; Sen. Juan ‘Chuy’ Hinojosa (Texas District 20, D-McAllen); McAllen Mayor Jim Darling; Dr. John Krouse, UTRGV vice president for Medical Affairs and dean of the School of Medicine; and UTRGV President Guy Bailey. Photo by Roberto Hugo Gonzalez

Mega Doctor News

- Advertisement -

By Jennifer L. Berghom 

EDINBURG, TEXAS – OCT. 11, 2017 – The City of McAllen presented a $1 million check to The University of Texas Rio Grande Valley School of Medicine on Wednesday, in support of the school’s mission to educate students and residents and provide increased access to healthcare.

The payment is part of a memorandum of understanding UTRGV signed with McAllen and other Valley cities to support and ensure the success of the School of Medicine.

- Advertisement -

“We are grateful for the City of McAllen’s support of the School of Medicine,” said UTRGV President Guy Bailey. “These funds will support UTRGV and the School of Medicine in its mission to engage in innovative research, clinical care and the training of the next generation of physicians for the Rio Grande Valley.”

McAllen Mayor Jim Darling said the payment by the City of McAllen is its contribution to help improve the health and prosperity of the region.

“In order to help the entire Rio Grande Valley grow and improve – as a community, in business, and most importantly, in our health – then a strong and vibrant UTRGV School of Medicine is tantamount to help make that possible,” he said.

Dr. John H. Krouse, dean of the School of Medicine and vice president for Health Affairs, said McAllen’s support further solidifies the partnership between the UTRGV School of Medicine and the communities it serves.

- Advertisement -

“It will allow our faculty, medical residents and students to continue providing healthcare to those who otherwise would not have access to care,” Krouse said, “and it will help fund the innovative research that addresses the healthcare needs of the Valley community.”

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Robotic Surgery Program Expanded at STHS McAllen

From smaller incisions and less pain to shorter hospital stays and faster recovery times, robotic-assisted surgery is changing the way patients experience surgical care.

Texas Oncology to Host Breast Cancer Awareness Symposium in McAllen. FULL TO CAPACITY. NO MORE ROOM.

The Breast Cancer Awareness Symposium 2026 is an educational and networking event hosted by Texas Oncology and sponsored by Caris Life Sciences, bringing together oncology specialists, surgeons, advanced practice providers, and community healthcare professionals to discuss the latest advances in breast cancer prevention, diagnosis, treatment, survivorship, and reconstruction. The symposium's theme, "Breast Cancer 2026: Early Detection, Modern Care, and Survivorship Through Community Partnership," highlights the importance of multidisciplinary collaboration and patient-centered care

Highway Crash Leads to Unexpected STC Connection

What began as a flat tire on the side of a highway turned into a frightening collision and an unexpected encounter for South Texas College faculty member Jesus Amaya, when the paramedic who responded to the scene turned out to be one of STC’s graduates.

FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer

The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for some patients with stage 3 colon cancer following surgery. The treatment is for patients whose tumors have deficient DNA mismatch repair, or dMMR.
- Advertisement -